EVALUATION OF ENZYME PRODUCTION BY CANDIDA SPP. ISOLATED FROM PATIENTS WITH ONYCHOMYCOSIS IN HUE CITY
Main Article Content
Abstract
Objective: To evaluate the production of virulence-associated enzymes, including protease, phospholipase, and lipase, in Candida albicans, Candida tropicalis and Candida parapsilosis isolated from patients with onychomycosis.
Methods: A cross-sectional descriptive study was conducted on 90 Candida isolates obtained from patients diagnosed with Candida onychomycosis. Species identification was performed using carbohydrate assimilation tests with the API 20C system (bioMérieux–Vitek, France). Protease, phospholipase, and lipase activities were assessed using the spot inoculation method on specific enzyme-detecting media, following previously published protocols.
Results: The overall proportions of Candida spp. exhibiting protease, lipase, and phospholipase activity were 82.2%, 77.8%, and 36.7%, respectively. Both C. albicans and C. tropicalis demonstrated very high levels of protease and lipase activity (100% and 96.7%, respectively), whereas C. parapsilosis predominantly showed absent or low enzymatic activity; this difference was statistically significant (p<0.001). All three species exhibited low phospholipase activity; however, C. albicans showed a significantly higher positivity rate compared with the other species (p<0.001). Most clinical forms of Candida onychomycosis were associated with high frequencies of protease and lipase activity, with no statistically significant differences among clinical presentations (p>0.05). In contrast, phospholipase activity varied significantly across different clinical manifestations (p<0.05).
Conclusion: Candida spp. causing onychomycosis exhibit high rates of protease and lipase production, highlighting the important role of these enzymes in fungal pathogenicity. Although phospholipase is produced at a lower frequency, its activity is significantly associated with more invasive clinical forms of nail involvement.
Article Details
Keywords
Candida spp., enzyme production, onychomycosis.
References
2. Gregoriou S, Mpali N, Vrioni G, Hatzidimitriou E, Chryssou SE, Rigopoulos D. Epidemiology of Onychomycosis in an Academic Nail Unit in South Greece during a Three-Year Period. Skin appendage disorders. 2020;6(2):102-7. doi: 10.1159/000504812.
3. Hoàng Hồng Mạnh, Trần Cẩm Vân, Nguyễn Thị Hà Vinh. Đặc điểm sinh học của chủng nấm sợi gây bệnh nấm móng. Tạp chí Y học Việt Nam. 2024;535(1):279-82.
4. Jabrodini A, Eghtedarnejad E, Ghanbarzadeh A, Motamedi M, Jafari M, Kharazi M, et al. Molecular identification and antifungal susceptibility profile of rare and emerging yeast species causing onychomycosis. BMC research notes. 2025;18(1):167. doi: 10.1186/s13104-025-07197-0.
5. Paškevičius A, Svediene J, Kiveryte S, Bridžiuvienė D, Vaitonis G, Jablonskiene V. Candida Distribution in Onychomycosis and in vitro Susceptibility to Antifungal Agents. Acta dermatovenerologica Croatica : ADC. 2020;28:204-9.
6. Mohammadi F, Ghasemi Z, Familsatarian B, Salehi E, Sharifynia S, Barikani A, et al. Relationship between antifungal susceptibility profile and virulence factors in Candida albicans isolated from nail specimens. Revista da Sociedade Brasileira de Medicina Tropical. 2020;53:e20190214. doi: 10.1590/0037-8682-0214-2019.
7. Sav H, Baris A, Turan D, Altinbas R, Sen S. The frequency, antifungal susceptibility and enzymatic profiles of Candida species in cases of onychomycosis infection. Microbial pathogenesis. 2018;116:257-62. doi: 10.1016/j.micpath.2018.01.036.
8. Ziccardi M, Souza LO, Gandra RM, Galdino AC, Baptista AR, Nunes AP, et al. Candida parapsilosis (sensu lato) isolated from hospitals located in the Southeast of Brazil: Species distribution, antifungal susceptibility and virulence attributes. International journal of medical microbiology : IJMM. 2015;305(8):848-59. doi: 10.1016/j.ijmm.2015.08.003.
9. Neji S, Hadrich I, Trabelsi H, Abbes S, Cheikhrouhou F, Sellami H, et al. Virulence factors, antifungal susceptibility and molecular mechanisms of azole resistance among Candida parapsilosis complex isolates recovered from clinical specimens. Journal of biomedical science. 2017;24(1):67. doi: 10.1186/s12929-017-0376-2.
10. Kantarcioglu AS, Yücel A. Phospholipase and protease activities in clinical Candida isolates with reference to the sources of strains. Mycoses. 2002;45(5-6):160-5. doi: 10.1046/j.1439-0507.2002.00727.x.
11. Maheronnaghsh M, Fatahinia M, Dehghan P, Zarei Mahmoudabadi PA, Kheirkhah M. Comparison of Virulence Factors of Different Candida Species Isolated from the Oral Cavity of Cancer Patients and Normal Individuals. Jundishapur Journal of Microbiology. 2019;In Press. doi: 10.5812/jjm.91556.
12. Ramos-Pardo A, Castro-Álvarez R, Quindós G, Eraso E, Sevillano E, Kaberdin VR. Assessing pH-dependent activities of virulence factors secreted by Candida albicans. MicrobiologyOpen. 2023;12(1):e1342. doi: 10.1002/mbo3.1342.
13. Mayer FL, Wilson D, Hube B. Candida albicans pathogenicity mechanisms. Virulence. 2013;4(2):119-28. doi: 10.4161/viru.22913.
14. Dagdeviren M, Cerikcioglu N, Karavus M. Acid proteinase, phospholipase and adherence properties of Candida parapsilosis strains isolated from clinical specimens of hospitalised patients. Mycoses. 2005;48(5):321-6. doi: 10.1111/j.1439-0507.2005.01145.x.
15. Gácser A, Trofa D, Schäfer W, Nosanchuk JD. Targeted gene deletion in Candida parapsilosis demonstrates the role of secreted lipase in virulence. The Journal of clinical investigation. 2007;117(10):3049-58. doi: 10.1172/jci32294.
16. Trofa D, Gácser A, Nosanchuk Joshua D. Candida parapsilosis, an Emerging Fungal Pathogen. Clinical Microbiology Reviews. 2008;21(4):606-25. doi: 10.1128/cmr.00013-08.